According to a new research study, straight tip guidewires, with a current share of more than a third of the total market value, will retain the dominant position in neurovascular guidewires market through 2028. The report from Future Market Insights notes that aneurysms and intra-and extra-cranial angioplasty reflect highest applicability of neurovascular guidewires.

A program designed to help heart attack patients with the transition from hospital to outpatient care can reduce readmissions and deaths and increase the number of patients keeping follow-up appointments, a new study suggests. Findings from the Sanger Heart and Vascular Heart Care Navigation Team study were presented at the American College of Cardiology’s Cardiovascular Summit, Feb. 14-16 in Orlando, Fla. The conference brings together top experts to discuss and review innovative, relevant cardiovascular management and leadership strategies.

DiA Imaging Analysis announced the launch of LVivo SAX, a cardiac analysis tool that helps clinicians quickly and accurately interpret ultrasound images and assess heart functionality among patients suspected of suffering from acute coronary syndrome (ACS).

Rolling Stones frontman Mick Jagger is reportedly recovering after undergoing a transcatheter aortic valve valve replacement (TAVR) procedure at a New York hospital.


Echocardiography reporting systems are usually integrated with, or offered as an add-on module for a cardiovascular information system (cardiac PACS). As technology has advanced, some cardiac ultrasound reporting systems have added advanced functionality that go beyond just offering a form to enter a text report.


Diagnostic and Interventional Cardiology (DAIC) was recently recognized as a finalist in the Jesse H. Neal Awards for the third year in a row, and DAIC won the award for best technical content for its team coverage of the potential safety issues related to gadolinium-based MRI contrast agents. The Neals are recognized as the Pulitzer Prize of the business press. 

 

TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) granted premarket approval for its SuperSaturated Oxygen (SSO2) Therapy. SSO2 Therapy provides interventional cardiologists with the first and only FDA-approved treatment beyond percutaneous coronary intervention (PCI) to significantly reduce muscle damage in heart attack patients.

Healthereum LLC released the beta version of the Healthereum Life Portfolio, or HELIO, a mobile application that allows patients to be rewarded digital tokens for interacting with their healthcare providers. With each action taken — “Promise to Show” for an appointment, complete quality care surveys after the visit, receive task messages from their doctors and view their current diagnoses — digital tokens are given to the patients’ “wallet” to reward them for time spent on their health using blockchain technology.

Subscribe Now